H1 2016 Lyme Disease Pipeline Market Research Report

04 Apr, 2016, 02:00 ET from RnR Market Research

PUNE, India, April 4, 2016 /PRNewswire/ --

RnRMarketResearch.com adds, "Lyme Disease - Pipeline Review, H1 2016," to its store. The report provides an overview of the Lyme Disease's therapeutic pipeline with comprehensive information on the therapeutic development for Lyme Disease, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Lyme Disease and special features on late-stage and discontinued projects.

Complete report on H1 2016 pipeline review of Lyme Disease with 15 market data tables and 12 figures, spread across 33 pages is available at http://www.rnrmarketresearch.com/lyme-disease-pipeline-review-h1-2016-market-report.html .

The report also reviews key players involved in the therapeutic development for Lyme Disease and special features on late-stage and discontinued projects. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products.

Companies discussed in this Lyme Disease Pipeline Review, H1 2016 report include LondonPharma Ltd, Valneva SE. Drug profiles discussed in this research report includes azithromycin, Lyme disease vaccine 2, Nu-3, Small Molecule for Lyme Disease and VLA-15.

Order a purchase copy of this report @ http://www.rnrmarketresearch.com/contacts/purchase?rname=516285 .

Scope of this report: The report provides a snapshot of the global therapeutic landscape of Lyme Disease and reviews pipeline therapeutics for Lyme Disease by companies and universities/research institutes based on information derived from company and industry-specific sources and key players involved Lyme Disease therapeutics and enlists all their major and minor projects. The research covers pipeline products based on various stages of development ranging from pre-registration till discovery and undisclosed stages. The report features descriptive drug profiles for the pipeline products which includes, product description, descriptive MoA, R&D brief, licensing and collaboration details & other developmental activities and assesses Lyme Disease therapeutics based on drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. The report summarizes all the dormant and discontinued pipeline projects with latest news related to pipeline therapeutics for Lyme Disease.

List of Tables:

Number of Products under Development for Lyme Disease, H1 2016

Number of Products under Development by Companies, H1 2016

Comparative Analysis by Late Stage Development, H1 2016

Comparative Analysis by Clinical Stage Development, H1 2016

Comparative Analysis by Early Stage Development, H1 2016

Products under Development by Companies, H1 2016

Lyme Disease - Pipeline by LondonPharma Ltd, H1 2016

Lyme Disease - Pipeline by Valneva SE, H1 2016

Assessment by Monotherapy Products, H1 2016

Number of Products by Stage and Target, H1 2016

Number of Products by Stage and Mechanism of Action, H1 2016

Number of Products by Stage and Route of Administration, H1 2016

Number of Products by Stage and Molecule Type, H1 2016

Lyme Disease Therapeutics - Recent Pipeline Updates, H1 2016

Lyme Disease - Dormant Projects, H1 2016

Another newly published market research report titled ' Botulism - Pipeline Review, H1 2016' provides comprehensive information on the therapeutic development for Botulism, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news and press releases. It also reviews key players involved in the therapeutic development for Botulism and special features on late-stage and discontinued projects. The report enhances decision making capabilities and help to create effective counter strategies to gain competitive advantage. It strengthens R&D pipelines by identifying new targets and MOAs to produce first-in-class and best-in-class products. Botulism Pipeline market research report of 49 pages is available at http://www.rnrmarketresearch.com/botulism-pipeline-review-h1-2016-market-report.html .

Explore more reports on Infectious Diseases Therapeutics.

About Us:   

RnRMarketResearch.com is your single source for all market research needs. Our database includes 500,000+ market research reports from over 100+ leading global publishers & in-depth market research studies of over 5000 micro markets. With comprehensive information about the publishers and the industries for which they publish market research reports, we help you in your purchase decision by mapping your information needs with our huge collection of reports.

Connect with Us:  

G+ / Google Plus: https://plus.google.com/104156468549256253075/posts

Twitter: https://twitter.com/RnRMR

Facebook: https://www.facebook.com/pages/RnR-Market-Research/413488545356345

RSS / Feeds: http://www.rnrmarketresearch.com/feed

Contact:
Ritesh Tiwari
UNIT no 802, Tower no. 7, SEZ
Magarpatta city, Hadapsar
Pune - 411013
Maharashtra, India.
Tel:  +1-888-391-5441
sales@rnrmarketresearch.com

SOURCE RnR Market Research